Let’s say for the sake of discussion that the Mets will trade Justin Verlander and Max Scherzer this month.
Here are two related questions that have flown under the radar in recent days: Who exactly would lead the starting rotation next season, when the team will presumably have similar championship aspirations?
And would replacing the two future Hall of Famers this winter lead the Mets to compromise their long-term future far more than they already have?
For all that has gone wrong with the 2023 Mets, one aspect of the team’s strategy continues to look very wise: The aversion to long-term free agent contracts for starting pitchers.
Verlander and Scherzer have underperformed, but the brevity of their contracts (two years plus a player opt-in for Scherzer; two years plus a vesting option for Verlander) means that their declines will not hamstring the Mets for long.
For all their spending last offseason, Brandon Nimmo’s eight-year deal was the only Mets contract of an irrational length.
The team stood back with no small measure of relief and watched the Texas Rangers offer Jacob deGrom five years, and the Yankees offer Carlos Rodon six. DeGrom has undergone Tommy John surgery since then; Rodon recently made his season debut, and could yet become a Yankee champion -- but so far, Verlander has been the most productive of the trio in 2023, with the added benefit of being a short-timer.
Without Verlander and Scherzer, the Mets would have Kodai Senga, Jose Quintana, David Peterson and Tylor Megill as their top four options for next year’s rotation. They will obviously add to that, but it will be tricky to do so without introducing the type of long-term risk that they have so far avoided.